Characterisation of the tumour necrosis factor (TNF)-(alpha) response elements in the human ICAM-2 promoter
- PMID:10574717
- DOI: 10.1242/jcs.112.24.4695
Characterisation of the tumour necrosis factor (TNF)-(alpha) response elements in the human ICAM-2 promoter
Abstract
ICAM-2 is a cell surface adhesion molecule constitutively expressed on the endothelium, involved in leukocyte recruitment into tissues. We recently showed that pro-inflammatory cytokines tumour necrosis factor (TNF)-(alpha) and interleukin (IL)-1(beta) down-regulate ICAM-2 expression at the transcriptional level. Here we investigate the elements in the ICAM-2 promoter required for the TNF-(alpha)-mediated down-regulation. Site directed mutagenesis of the ICAM-2 promoter implicated three consensus sites for Ets transcription factors in basal activity; two of these sites were also involved in the TNF-(alpha)-induced down-regulation. Electrophoretic mobility shift assays (EMSA) performed in human umbilical vein endothelial cells (HUVEC) showed that all three Ets binding sites (EBS) bind nuclear proteins. TNF-(alpha) treatment (10 ng/ml for 24 hours) decreased binding to the double -135/-127EBS, but not to the -44EBS. The Ets family member Erg was found to be constitutively expressed in HUVEC, and TNF-(alpha) down-regulated Erg protein levels. Furthermore, an Erg cDNA transactivated the ICAM-2 promoter when transiently transfected into both HeLa cells and HUVEC. Protein expression of ICAM-2 and Erg was found to be similarly regulated by TNF-(alpha) in an ex vivo artery model. These data suggest that constitutive endothelial genes ICAM-2 and Erg are on the same pathway of cytokine-dependent regulation of gene expression.
Similar articles
- Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta down-regulate intercellular adhesion molecule (ICAM)-2 expression on the endothelium.McLaughlin F, Hayes BP, Horgan CM, Beesley JE, Campbell CJ, Randi AM.McLaughlin F, et al.Cell Adhes Commun. 1998;6(5):381-400. doi: 10.3109/15419069809109147.Cell Adhes Commun. 1998.PMID:10223354
- The transcription factor Erg inhibits vascular inflammation by repressing NF-kappaB activation and proinflammatory gene expression in endothelial cells.Sperone A, Dryden NH, Birdsey GM, Madden L, Johns M, Evans PC, Mason JC, Haskard DO, Boyle JJ, Paleolog EM, Randi AM.Sperone A, et al.Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):142-50. doi: 10.1161/ATVBAHA.110.216473. Epub 2010 Oct 21.Arterioscler Thromb Vasc Biol. 2011.PMID:20966395
- Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation.McLaughlin F, Ludbrook VJ, Cox J, von Carlowitz I, Brown S, Randi AM.McLaughlin F, et al.Blood. 2001 Dec 1;98(12):3332-9. doi: 10.1182/blood.v98.12.3332.Blood. 2001.PMID:11719371
- Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.Schwachtgen JL, Janel N, Barek L, Duterque-Coquillaud M, Ghysdael J, Meyer D, Kerbiriou-Nabias D.Schwachtgen JL, et al.Oncogene. 1997 Dec 18;15(25):3091-102. doi: 10.1038/sj.onc.1201502.Oncogene. 1997.PMID:9444957
- Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T.Collins T, et al.FASEB J. 1995 Jul;9(10):899-909.FASEB J. 1995.PMID:7542214Review.
Cited by
- Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target.Greulich BM, Plotnik JP, Jerde TJ, Hollenhorst PC.Greulich BM, et al.NAR Cancer. 2021 Jan 27;3(1):zcaa046. doi: 10.1093/narcan/zcaa046. eCollection 2021 Mar.NAR Cancer. 2021.PMID:33554122Free PMC article.
- Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells.Seeger FH, Chen L, Spyridopoulos I, Altschmied J, Aicher A, Haendeler J.Seeger FH, et al.PLoS One. 2009;4(2):e4529. doi: 10.1371/journal.pone.0004529. Epub 2009 Feb 19.PLoS One. 2009.PMID:19225563Free PMC article.
- Selective inhibition of the human tie-1 promoter with triplex-forming oligonucleotides targeted to Ets binding sites.Hewett PW, Daft EL, Laughton CA, Ahmad S, Ahmed A, Murray JC.Hewett PW, et al.Mol Med. 2006 Jan-Mar;12(1-3):8-16. doi: 10.2119/2005-00046.Hewett.Mol Med. 2006.PMID:16838069Free PMC article.
- Erythro-myeloid progenitors contribute endothelial cells to blood vessels.Plein A, Fantin A, Denti L, Pollard JW, Ruhrberg C.Plein A, et al.Nature. 2018 Oct;562(7726):223-228. doi: 10.1038/s41586-018-0552-x. Epub 2018 Sep 26.Nature. 2018.PMID:30258231Free PMC article.
- A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice.Liu J, Kanki Y, Okada Y, Jin E, Yano K, Shih SC, Minami T, Aird WC.Liu J, et al.J Thromb Haemost. 2009 Aug;7(8):1384-92. doi: 10.1111/j.1538-7836.2009.03501.x. Epub 2009 May 30.J Thromb Haemost. 2009.PMID:19496923Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous